StockWatch
·
Healthcare Service Provider
Clarification15 Sept 2026, 02:36 pm

Modern Diagnostic Denies Undisclosed Price Sensitive Information

AI Summary

Modern Diagnostic & Research Centre Ltd has responded to a BSE query regarding significant price movements in its securities. The company stated that, to the best of its knowledge, there is no unpublished price-sensitive information (UPSI) or material event that has not been disclosed and could be influencing the stock price. They clarified that no information requiring disclosure under SEBI regulations is being withheld. The company attributes the price movement purely to market forces and has no specific knowledge of the reasons behind it. Modern Diagnostic reiterates its commitment to regulatory compliance and timely disclosures.

Key Highlights

  • Company denies any undisclosed price-sensitive information.
  • Price movement attributed solely to market-driven factors.
  • No material events requiring immediate disclosure exist.
  • Commitment to SEBI regulations and timely disclosures reaffirmed.